Literature DB >> 23221192

Nosocomial transmission of New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in Toronto, Canada.

Christopher F Lowe1, Julianne V Kus, Natasha Salt, Sandra Callery, Lisa Louie, Mohammed A Khan, Mary Vearncombe, Andrew E Simor.   

Abstract

DESIGN: An analysis of a cluster of New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae (NDM1-Kp) and a retrospective case-cohort analysis of risk factors for acquisition in contacts of NDM1-Kp-positive patients.
SETTING: A 1,100-bed Canadian academic tertiary care center. PATIENTS: Two index patients positive for NDM1-Kp as well as 45 contacts (roommates, ward mates, or environmental contacts) were investigated.
METHODS: Retrospective chart reviews of all patients colonized or infected with NDM1-Kp as well as contacts of these patients were performed in order to describe the epidemiology and impact of infection prevention and control measures. A case-cohort analysis was conducted investigating 45 contacts of NDM1-Kp-positive patients to determine risk factors for acquisition of NDM1-Kp. Rectal swabs were screened for NDM1-Kp using chromogenic agar. Presence of bla(NDM-1) was confirmed by multiplex polymerase chain reaction. Clonality was assessed with pulsed-field gel electrophoresis (PFGE) using restriction enzyme XbaI.
RESULTS: Two index cases carrying NDM1-Kp with different PFGE patterns were identified. Nosocomial transmission to 7 patients (4 roommates, 2 ward mates, and 1 environmental contact) was subsequently identified. Risk factors for acquisition of NDM1-Kp were a history of prior receipt of certain antibiotics (fluoroquinolones [odds ratio (OR), 16.8 (95% confidence interval [CI], 1.30-58.8); [Formula: see text]], trimethoprim-sulfamethoxazole [OR, 11.3 (95% CI, 1.84-70.0); [Formula: see text]], and carbapenems [OR, 16.8 (95% CI, 1.79-157.3); [Formula: see text]]) and duration of exposure to NDM1-Kp-positive roommates (26.5 vs 6.7 days; [Formula: see text]).
CONCLUSION: Two distinct clones of NDM1-Kp were transmitted to 7 inpatient contacts over several months. Implementation of contact precautions, screening of contacts for NDM1-Kp carriage, and attention to environmental disinfection contributed to the interruption of subsequent spread of the organism. The appropriate duration and frequency of screening contacts of NDM1-Kp-positive patients require further study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23221192     DOI: 10.1086/668778

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  19 in total

1.  Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches.

Authors:  Tara N Palmore; David K Henderson
Journal:  Clin Infect Dis       Date:  2013-08-09       Impact factor: 9.079

Review 2.  Colonization resistance: The deconvolution of a complex trait.

Authors:  Erin E Olsan; Mariana X Byndloss; Franziska Faber; Fabian Rivera-Chávez; Renée M Tsolis; Andreas J Bäumler
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

3.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 4.  Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.

Authors:  Jessica Tischendorf; Rafael Almeida de Avila; Nasia Safdar
Journal:  Am J Infect Control       Date:  2016-02-15       Impact factor: 2.918

Review 5.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

6.  Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.

Authors:  Jasmine Ahmed-Bentley; A Uma Chandran; A Mark Joffe; Desiree French; Gisele Peirano; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

7.  Epidemiologic and Genotypic Review of Carbapenemase-Producing Organisms in British Columbia, Canada, between 2008 and 2014.

Authors:  Inna Sekirov; Matthew A Croxen; Corrinne Ng; Robert Azana; Yin Chang; Laura Mataseje; David Boyd; Chand Mangat; Benjamin Mack; Manal Tadros; Elizabeth Brodkin; Pamela Kibsey; Aleksandra Stefanovic; Sylvie Champagne; Michael R Mulvey; Linda M N Hoang
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

8.  Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.

Authors:  Hosam M Zowawi; Anna L Sartor; Hanan H Balkhy; Timothy R Walsh; Sameera M Al Johani; Reem Y AlJindan; Mubarak Alfaresi; Emad Ibrahim; Amina Al-Jardani; Seif Al-Abri; Jameela Al Salman; Ali A Dashti; Abdullah H Kutbi; Sanmarié Schlebusch; Hanna E Sidjabat; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

Review 9.  Salmonella versus the Microbiome.

Authors:  Andrew W L Rogers; Renée M Tsolis; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2020-12-23       Impact factor: 11.056

10.  Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).

Authors:  Brigitte Lefebvre; Simon Lévesque; Anne-Marie Bourgault; Michael R Mulvey; Laura Mataseje; David Boyd; Florence Doualla-Bell; Cécile Tremblay
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.